mast cell activation syndrome
GPTKB entity
Statements (35)
| Predicate | Object |
|---|---|
| gptkbp:instanceOf |
gptkb:disease
|
| gptkbp:abbreviation |
gptkb:MCAS
|
| gptkbp:affects |
gptkb:mast_cells
multiple organ systems |
| gptkbp:causedBy |
abnormal mast cell activation
|
| gptkbp:diagnosedBy |
laboratory tests
clinical criteria response to treatment |
| gptkbp:field |
gptkb:allergy
immunology |
| gptkbp:firstDescribed |
2007
|
| https://www.w3.org/2000/01/rdf-schema#label |
mast cell activation syndrome
|
| gptkbp:ICD-10_code |
D89.4
|
| gptkbp:prevalence |
rare
|
| gptkbp:relatedTo |
gptkb:systemic_mastocytosis
allergic reactions |
| gptkbp:riskFactor |
genetic predisposition
environmental triggers |
| gptkbp:symptom |
diarrhea
abdominal pain fatigue headache anaphylaxis flushing hives brain fog |
| gptkbp:treatment |
corticosteroids
epinephrine antihistamines leukotriene inhibitors mast cell stabilizers |
| gptkbp:bfsParent |
gptkb:hypermobile_Ehlers-Danlos_syndrome
gptkb:postural_orthostatic_tachycardia_syndrome gptkb:Mast_Cell_360 |
| gptkbp:bfsLayer |
7
|